Agilent Technologies Inc
NYSE:A

Watchlist Manager
Agilent Technologies Inc Logo
Agilent Technologies Inc
NYSE:A
Watchlist
Price: 136.1 USD 1.11% Market Closed
Market Cap: 39.1B USD
Have any thoughts about
Agilent Technologies Inc?
Write Note

Agilent Technologies Inc
Investor Relations

Agilent Technologies Inc., a spin-off from Hewlett-Packard in 1999, has cultivated a niche in the vibrant landscape of the life sciences, diagnostics, and applied chemical markets. This California-based company, born from the legacy of one of Silicon Valley’s pioneers, has carved out its identity by providing sophisticated analytical instrumentation, software, services, and consumables for a wide range of applications. Agilent's businesses are stitched together by an underlying technology expertise, which forms the bedrock for its product lines that serve an increasing demand for precise and reliable analytical measurements. From cutting-edge liquid chromatography to mass spectrometry and genetic analysis systems, Agilent's offerings are geared towards supporting research and quality control processes across various industries, including pharmaceuticals, food safety, and environmental testing. The company's commitment to innovation and quality has consistently positioned it as a trusted partner in advancing the capabilities of laboratories worldwide.

Agilent's revenue generation hinges on a strategic blend of product sales and services. The core of its business model revolves around not just selling instruments, but also establishing long-term relationships through service agreements, maintenance, and training. This recurring service revenue complements the sale of consumables and parts required for the operation of their sophisticated instruments. Additionally, Agilent has strategically expanded its footprint in the diagnostics market, providing instruments and reagents used in pathology laboratories, further diversifying its income streams. With a deliberate focus on high-growth areas, including genomics and cancer diagnostics, Agilent continues to leverage its technological prowess and industry expertise to capture market share in sectors that are inherently driven by the necessity for innovation and regulatory compliance. Through an intricate balance of hardware sales and consistent after-sale support, Agilent steadily maintains its role as a formidable player in the analytical instrumentation sector.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Mr. Rodney Gonsalves
Principal Accounting Officer, VP & Corporate Controller

Rodney Gonsalves is the Vice President and Chief Accounting Officer at Agilent Technologies Inc. He specializes in finance and accounting functions, including financial reporting, auditing, and compliance. Gonsalves has extensive experience in leading and managing finance teams, focusing on delivering financial insights and maintaining rigorous standards of accuracy and efficiency. He plays a critical role in Agilent Technologies' financial health, ensuring that all accounting practices adhere to the highest standards and regulations. Prior to his role at Agilent, he gathered substantial experience in varied finance roles across different organizations, contributing significantly to strategic financial planning and execution.

Mr. John Kohl
Senior Vice President & Chief Information Officer

John Kohl is the Senior Vice President, General Counsel, and Secretary at Agilent Technologies, Inc. He plays a pivotal role in overseeing the global legal affairs of the company, providing strategic guidance on legal, regulatory, and compliance matters. Kohl has been instrumental in shaping and navigating Agilent's legal strategies and policies, ensuring adherence to increasing regulatory requirements across various markets. With a robust legal background and significant experience in the technology and healthcare sectors, John Kohl has contributed to Agilent's growth and success in the industry. His leadership extends beyond legal counsel, as he participates in key executive decisions, corporate governance, and risk management initiatives. Kohl joined Agilent Technologies with a wealth of experience gained from his previous roles in prestigious law firms and other corporations. His expertise spans various areas, including intellectual property, mergers and acquisitions, and legal risk management, making him a valuable asset to Agilent's executive team.

Mr. Bret M. DiMarco
Senior VP, Chief Legal Officer, & Secretary

Bret M. DiMarco serves as the Senior Vice President, General Counsel, and Secretary of Agilent Technologies Inc. In his role, DiMarco oversees Agilent's global legal, intellectual property, and compliance functions. He plays a critical role in guiding the company through complex legal landscapes, ensuring compliance with regulations, and protecting Agilent's intellectual property assets. DiMarco's leadership is instrumental in supporting Agilent's business goals and maintaining its ethical standards across its global operations. His extensive experience and expertise in legal affairs contribute significantly to the company's strategic initiatives and growth.

Mr. Dominique P. Grau
Senior Vice President of Human Resources & Global Communications

Dominique P. Grau is a notable executive at Agilent Technologies Inc. He serves as the Senior Vice President of Quality and Regulatory Affairs for the company. In his role, he oversees global quality assurance, regulatory affairs, and compliance functions. His responsibilities include ensuring that Agilent’s products adhere to the highest quality standards and meet regulatory requirements across different markets. Mr. Grau has extensive experience in quality and regulatory roles, contributing significantly to the life sciences and diagnostics sectors. His expertise is integral to maintaining Agilent's reputation for excellence in providing trusted analytical solutions and ensuring the company’s products contribute to customer success. In addition to his current role, Dominique P. Grau's career includes various leadership positions, where he has demonstrated his adeptness at managing complex regulatory landscapes and driving improvement initiatives. His educational background and career trajectory underline his commitment to quality and compliance, positioning him as a key figure in Agilent's leadership team.

Ms. Yvonne Mackie
MD of UK & Ireland Operations and VP of Human Resources - Europe
No Bio Available
Ms. Jenipher E. Dalton
Senior VP, Chief Quality & Regulatory Officer

Jenipher E. Dalton is an executive at Agilent Technologies Inc., where she holds the position of Vice President, Assistant General Counsel, and Assistant Secretary. In her role, Dalton plays a crucial part in overseeing legal matters and corporate governance at Agilent, a leading global company in the life sciences, diagnostics, and applied chemical markets. Her responsibilities typically involve managing legal risks, supporting business strategies, providing legal guidance on transactions, and ensuring regulatory compliance. Through her expertise and leadership, Dalton contributes to Agilent’s mission of advancing the quality of life by providing cutting-edge technology solutions.

Mr. Philip Binns
Senior VP of Agilent and President of Life Sciences & Applied Markets Group

Philip Binns is recognized for his role at Agilent Technologies, where he has made significant contributions. Serving as Senior Vice President, he oversees the Chemical & Energy, Food, and Pharma business unit in the company's Life Sciences and Applied Markets Group. Under his leadership, these sectors have successfully advanced in developing and deploying innovative solutions that meet varied industry needs. Binns' strategic insights and management acumen have played a crucial role in navigating complex market landscapes and expanding Agilent's position within these critical industries. His extensive experience in technology and market strategy continues to serve as a valuable asset to Agilent Technologies.

Ms. Angelica Riemann III
Senior Vice President
No Bio Available
Dr. Simon May
SVP of Agilent & President of Diagnostics & Genomics Group

Dr. Simon May is a prominent figure at Agilent Technologies Inc., where he holds a significant leadership role. As of the latest information, he serves as the Vice President and General Manager of the Mass Spectrometry Division. Dr. May is responsible for overseeing the strategic direction, development, and global operations of Agilent’s mass spectrometry business, a core area within the life sciences and applied markets. With a strong academic background in chemistry, Dr. May has extensive expertise in analytical instrumentation, having garnered numerous years of experience in the field. Before joining Agilent, he held various roles that contributed to his deep understanding of scientific research and development, as well as business management. Throughout his career at Agilent, Dr. May has been instrumental in driving innovation and advancing the company’s technological capabilities in mass spectrometry. His leadership has been key to enhancing Agilent's position as a leader in providing solutions for complex analytical challenges across various industries, including pharmaceuticals, environmental, and food safety sectors. Dr. May's contributions are recognized within the scientific community and industry, noted for his commitment to promoting scientific excellence and fostering collaborative relationships to advance the capabilities and applications of mass spectrometry technologies.

Contacts

Address
CALIFORNIA
Santa Clara
5301 Stevens Creek Blvd
Contacts
+14083458886.0
www.agilent.com